CAMPBELL, Calif.--(BUSINESS WIRE)--Today, Saama announced the release of several groundbreaking features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL), creating an unparalleled, workflow-driven environment for cross-functional collaboration.

加利福尼亚州坎贝尔（商业新闻短讯）--今天，萨玛宣布在其人工智能驱动的平台上发布了一些开创性的功能，包括生成人工智能（GenAI）聊天和交互式评论列表（IRL），为跨功能协作创造了一个无与伦比的工作流驱动环境。

For the first time, users can ask questions of their data in natural language, and instantly receive responses – eliminating costly data analysis delays. Additionally, data management and medical review teams can now work together in a single system to complete comprehensive data reviews from start to finish..

用户第一次可以用自然语言询问他们的数据，并立即收到回复，从而消除了昂贵的数据分析延迟。此外，数据管理和医疗审查团队现在可以在一个系统中协同工作，从头到尾完成全面的数据审查。。

“Outdated approaches to clinical development are delaying treatments from making it to market, and ultimately patients,” said Lisa Moneymaker, Chief Technology Officer and Chief Product Officer, Saama. “These cutting-edge features embedded within the Saama platform create a collaborative environment where AI can quickly surface insights and drive users to action.

Saama首席技术官兼首席产品官丽莎·莫尼梅克（LisaMoneymaker）表示：“过时的临床开发方法正在推迟治疗上市，最终会延误患者。”。“Saama平台中嵌入的这些尖端功能创造了一个协作环境，人工智能可以在其中快速展示见解并推动用户采取行动。

The result is the breakdown of operational silos and the acceleration of development timelines.”.

其结果是运营孤岛的崩溃和开发时间表的加速。”。

Saama is fundamentally changing how drug development is done by integrating pioneering innovations into its award-winning platform. New features and enhancements now available include:

萨玛通过将开创性创新整合到其屡获殊荣的平台中，从根本上改变了药物开发的方式。现在提供的新功能和增强功能包括：

Interactive Review Listings (IRL): Data managers, medical monitors, and vendors can now work together in a single environment to complete comprehensive data reviews from start to finish. Powered by AI, Saama’s platform allows study teams to access and review the data they need without waiting for programmers.

交互式审查清单（IRL）：数据管理人员、医疗监护人员和供应商现在可以在单一环境中协同工作，从头到尾完成全面的数据审查。在人工智能的支持下，萨玛的平台允许研究团队访问和审查他们所需的数据，而无需等待程序员。

With IRL, users can create custom listings using GenAI, and track all queries in a single location, regardless of source. Users can also collaborate with their teams by assigning tasks, raising and inspecting queries, and managing vendors all in one place..

使用IRL，用户可以使用GenAI创建自定义列表，并在单个位置跟踪所有查询，而不考虑来源。用户还可以通过分配任务、提出和检查查询以及管理供应商等方式与团队协作。。

Data Quality (DQ) Co-Pilot: Is a first-of-its-kind GenAI feature embedded within Smart Data Quality (SDQ) that eliminates the need to manually program, test, and deploy data quality checks. Data managers can describe their desired DQ check, and DQ Co-Pilot will generate accurate code and test data in seconds..

数据质量（DQ）副试点：是智能数据质量（SDQ）中嵌入的第一个GenAI功能，无需手动编程、测试和部署数据质量检查。数据管理员可以描述他们想要的DQ检查，DQ副驾驶将在几秒钟内生成准确的代码和测试数据。。

Chat for Patient Insights: Another breakthrough GenAI innovation, chat allows medical monitors to ask questions of their data in natural languages and receive the data they need in seconds. Medical monitors can quickly create custom listings without programmers or coding knowledge, saving weeks on data analysis..

聊天获取患者见解：另一项突破性的GenAI创新，聊天允许医疗监护仪以自然语言询问他们的数据问题，并在几秒钟内接收他们需要的数据。医疗监护仪可以快速创建自定义列表，而无需程序员或编码知识，从而节省数周的数据分析时间。。

Data Hub: Users can now apply different data standards by study, manage blinded datasets, as well as leverage Saama’s advanced, AI-driven data mapping feature for faster data standardization. This makes Data Hub an even more powerful tool for centrally managing clinical trial data.

数据中心：用户现在可以通过研究应用不同的数据标准，管理盲法数据集，以及利用Saama先进的人工智能驱动的数据映射功能来更快地实现数据标准化。这使得Data Hub成为集中管理临床试验数据的更强大工具。

Operational Insights: An all new interface allows executives and portfolio managers to quickly drill-down from high-level dashboards to study-level data on a single screen. The intuitive interface allows users to easily identify KPIs of interest and brings together data from multiple source systems in a single view..

操作见解：全新界面允许高管和投资组合经理从高级仪表板快速向下钻取，在单个屏幕上研究级别数据。直观的界面允许用户轻松识别感兴趣的KPI，并在单个视图中汇总来自多个源系统的数据。。

When using Saama’s innovative solutions, clinical trial sponsors and contract research organizations reduce the time from data capture to query generation by nearly one month and reduce the time to generate a single query by 90%.

当使用Saama的创新解决方案时，临床试验赞助商和合同研究组织将从数据捕获到查询生成的时间减少了近一个月，并将生成单个查询的时间减少了90%。

“At Saama, we are committed to fostering innovation so that we may best support the complex needs of, and ultimately deliver value to, our customers,” said Avi Kulkarni, Chief Customer Success and Growth Officer. “The continued evolution of the Saama platform provides the foundational tools to modernize R&D and allow clinical development teams to do what they do best – gain insights from data to drive medical breakthroughs.”.

首席客户成功与增长官阿维·库尔卡尼（AviKulkarni）表示：“在萨玛，我们致力于促进创新，以便最好地满足客户的复杂需求，并最终为客户带来价值。”。“Saama平台的不断发展为研发现代化提供了基础工具，并允许临床开发团队做他们最擅长的事情-从数据中获得见解以推动医学突破。”。

By applying AI and advanced analytics to key clinical development processes, Saama’s platform eliminates manual, resource-intensive activities, allowing life science organizations to optimize productivity as well as gain deeper insights into patients’ behaviors and their real-time response to treatments..

通过将人工智能和高级分析应用于关键的临床开发过程，Saama平台消除了手动的资源密集型活动，使生命科学组织能够优化生产力，并深入了解患者的行为及其对治疗的实时反应。。

To learn more about the Saama platform and its custom solutions and services, or to schedule a personalized demonstration, visit saama.com.

要了解有关Saama平台及其定制解决方案和服务的更多信息，或安排个性化演示，请访问Saama.com。

We also invite you to meet us at booth 132 at the SCOPE Summit from February 11-14 in Orlando, Florida.

我们还邀请您于2月11日至14日在佛罗里达州奥兰多举行的SCOPE峰会上，在132号展位与我们会面。

About Saama

关于Saama

Saama develops life science solutions that accelerate the delivery of therapies to patients. With innovative AI technologies, Saama drives breakthrough intelligence into clinical and commercial operations. The Saama platform powered the clinical trial that led to the world’s first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives.

Saama开发了生命科学解决方案，可以加速向患者提供治疗。凭借创新的人工智能技术，萨玛将突破性的智能应用于临床和商业运营。Saama平台为临床试验提供了动力，该试验产生了世界上第一种新型冠状病毒肺炎疫苗。萨玛公司总部位于加利福尼亚州坎贝尔，员工遍布全球，致力于帮助客户挽救和改善生活。

Discover more at saama.com..

更多信息请访问saama.com。。